{"id":2891,"date":"2020-08-01T04:03:54","date_gmt":"2020-08-01T09:03:54","guid":{"rendered":"https:\/\/patents.harnessip.com\/?p=2891"},"modified":"2020-08-23T23:07:02","modified_gmt":"2020-08-24T04:07:02","slug":"improved-method-of-operating-a-flow-cytometry-apparatus-is-not-abstract","status":"publish","type":"post","link":"https:\/\/patents.harnessip.com\/?p=2891","title":{"rendered":"Improved Method of Operating a Flow Cytometry Apparatus Is Not Abstract"},"content":{"rendered":"\n<p>In <a href=\"http:\/\/www.cafc.uscourts.gov\/sites\/default\/files\/opinions-orders\/19-1789.OPINION.7-31-2020_1628850.pdf\">XY, LLC v. Trans Ova Genetics, LC<\/a>, [2019-1789] (July 31, 2020), the Federal Circuit reversed the district court\u2019s judgment that the asserted claims of RE46559 are ineligible under \u00a7101, and vacate the district court\u2019s determination that claim-preclusion judgment, and remand for further proceedings certain claims of U.S. Patent Nos. 6,732,422, 7,723,116, and 8,652,769 were claim-precluded based on a prior lawsuit filed by XY against Trans Ova.<\/p>\n\n\n\n<p>The \u2018559 patent is directed to a method of operating a flow cytometry apparatus with at least n detectors to analyze at least two populations of particles in the same sample.\u00a0 At <em>Alice <\/em>step two the district court found that the claims were directed to the mathematical equation that permits rotating multi-dimensional data.\u00a0 At <em>Alice <\/em>step two, the district court held that the asserted claims lacked an inventive concept because XY admitted that each claim element was known in the art.<\/p>\n\n\n\n<p>Beginning its analysis with <em>Alice <\/em>step one, the Federal Circuit concluded that the district court erred when it held that the claims are directed to the mathematical equation that permits rotating multi-dimensional data.\u00a0 The Federal Circuit found that the claims are directed to a purportedly improved method of operating a flow cytometry apparatus.\u00a0 The Federal Circuit found the asserted \u2019559 patent claims were analogous to the claims at issue in <em>Diehr <\/em>and <em>Thales<\/em>.\u00a0 Like the claims in <em>Diehr<\/em>, the asserted claims \u201cdescribe in detail a step-by-step method\u201d for accomplishing a physical process.\u00a0 Like the claims in Thales, the claims are directed to a method in which at least two sensors or detectors gather data about an object before mathematical operations are applied to the gathered data to generate more accurate information about the object than was previously possible in the art.\u00a0 Having concluded that the asserted claims of the \u2019559 patent are not directed to an abstract idea at <em>Alice <\/em>step one, the Federal Circuit did not reach <em>Alice <\/em>step two.<\/p>\n\n\n\n<p>Turning to the issue of claim preclusion, the Federal Circuit said that the parties\u2019 only dispute concerned whether the district court properly concluded that XY\u2019s 2012 and 2016 lawsuits present the same cause of action. XY argues that the district court erred by failing to compare the currently asserted patent claims to the previously asserted patent claims to determine whether the causes of action in the two lawsuits are essentially the same, and the Federal Circuit agreed.\u00a0 The district court\u2019s holding was based solely on the fact that the earlier-asserted patents and the later-asserted patents shared a common specification and were continuations of, and terminally-disclaimed to, the same parent patent.\u00a0 The Federal Circuit concluded that the district court erred in its claim-preclusion analysis by failing to compare the scope of the patent claims asserted in the 2012 lawsuit with the scope of the patent claims asserted in the 2016 lawsuit, and vacated and remanded the case.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In XY, LLC v. Trans Ova Genetics, LC, [2019-1789] (July 31, 2020), the Federal Circuit reversed the district court\u2019s judgment that the asserted claims of RE46559 are ineligible under \u00a7101, and vacate the district court\u2019s determination that claim-preclusion judgment, and &hellip; <a href=\"https:\/\/patents.harnessip.com\/?p=2891\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-2891","post","type-post","status-publish","format-standard","hentry","category-15"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=\/wp\/v2\/posts\/2891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2891"}],"version-history":[{"count":1,"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=\/wp\/v2\/posts\/2891\/revisions"}],"predecessor-version":[{"id":2892,"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=\/wp\/v2\/posts\/2891\/revisions\/2892"}],"wp:attachment":[{"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patents.harnessip.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}